Selected research
Industry Research
Sotagliflozin Industry Research Report 2026
Market perspective
The global Sotagliflozin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sotagliflozin is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sotagliflozin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sotagliflozin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sotagliflozin include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sotagliflozin market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Sotagliflozin.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sotagliflozin Market by Company
Clearsynth
CSN Pharm
Mankind Pharma
Medchemexpress
Sanofi
Selleck Chemical
TargetMol
Viatris
Huikang Boyuan Chemical
Prisun Pharmatech
Vcare Pharmatech
Sotagliflozin Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Sotagliflozin Segment by Application
Research Institute
Pharmaceutical
Others
Sotagliflozin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sotagliflozin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sotagliflozin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sotagliflozin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sotagliflozin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sotagliflozin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sotagliflozin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥ 98 %
- Purity ≥ 99 %
Applications
- Research Institute
- Pharmaceutical
- Others
Companies covered
- Clearsynth
- CSN Pharm
- Mankind Pharma
- Medchemexpress
- Sanofi
- Selleck Chemical
- TargetMol
- Viatris
- Huikang Boyuan Chemical
- Prisun Pharmatech
- Vcare Pharmatech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Sotagliflozin by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Purity ≥ 98 %
- 2.2.3 Purity ≥ 99 %
- 2.3 Sotagliflozin by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Research Institute
- 2.3.3 Pharmaceutical
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Sotagliflozin Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Sotagliflozin Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Sotagliflozin Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Sotagliflozin Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sotagliflozin Production by Manufacturers (2021-2026)
- 3.2 Global Sotagliflozin Production Value by Manufacturers (2021-2026)
- 3.3 Global Sotagliflozin Average Price by Manufacturers (2021-2026)
- 3.4 Global Sotagliflozin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sotagliflozin Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Sotagliflozin Manufacturers, Product Type & Application
- 3.7 Global Sotagliflozin Manufacturers Established Date
- 3.8 Global Sotagliflozin Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Clearsynth
- 4.1.1 Clearsynth Sotagliflozin Company Information
- 4.1.2 Clearsynth Sotagliflozin Business Overview
- 4.1.3 Clearsynth Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Clearsynth Product Portfolio
- 4.1.5 Clearsynth Recent Developments
- 4.2 CSN Pharm
- 4.2.1 CSN Pharm Sotagliflozin Company Information
- 4.2.2 CSN Pharm Sotagliflozin Business Overview
- 4.2.3 CSN Pharm Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 CSN Pharm Product Portfolio
- 4.2.5 CSN Pharm Recent Developments
- 4.3 Mankind Pharma
- 4.3.1 Mankind Pharma Sotagliflozin Company Information
- 4.3.2 Mankind Pharma Sotagliflozin Business Overview
- 4.3.3 Mankind Pharma Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Mankind Pharma Product Portfolio
- 4.3.5 Mankind Pharma Recent Developments
- 4.4 Medchemexpress
- 4.4.1 Medchemexpress Sotagliflozin Company Information
- 4.4.2 Medchemexpress Sotagliflozin Business Overview
- 4.4.3 Medchemexpress Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Medchemexpress Product Portfolio
- 4.4.5 Medchemexpress Recent Developments
- 4.5 Sanofi
- 4.5.1 Sanofi Sotagliflozin Company Information
- 4.5.2 Sanofi Sotagliflozin Business Overview
- 4.5.3 Sanofi Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Sanofi Product Portfolio
- 4.5.5 Sanofi Recent Developments
- 4.6 Selleck Chemical
- 4.6.1 Selleck Chemical Sotagliflozin Company Information
- 4.6.2 Selleck Chemical Sotagliflozin Business Overview
- 4.6.3 Selleck Chemical Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Selleck Chemical Product Portfolio
- 4.6.5 Selleck Chemical Recent Developments
- 4.7 TargetMol
- 4.7.1 TargetMol Sotagliflozin Company Information
- 4.7.2 TargetMol Sotagliflozin Business Overview
- 4.7.3 TargetMol Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 TargetMol Product Portfolio
- 4.7.5 TargetMol Recent Developments
- 4.8 Viatris
- 4.8.1 Viatris Sotagliflozin Company Information
- 4.8.2 Viatris Sotagliflozin Business Overview
- 4.8.3 Viatris Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Viatris Product Portfolio
- 4.8.5 Viatris Recent Developments
- 4.9 Huikang Boyuan Chemical
- 4.9.1 Huikang Boyuan Chemical Sotagliflozin Company Information
- 4.9.2 Huikang Boyuan Chemical Sotagliflozin Business Overview
- 4.9.3 Huikang Boyuan Chemical Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Huikang Boyuan Chemical Product Portfolio
- 4.9.5 Huikang Boyuan Chemical Recent Developments
- 4.10 Prisun Pharmatech
- 4.10.1 Prisun Pharmatech Sotagliflozin Company Information
- 4.10.2 Prisun Pharmatech Sotagliflozin Business Overview
- 4.10.3 Prisun Pharmatech Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Prisun Pharmatech Product Portfolio
- 4.10.5 Prisun Pharmatech Recent Developments
- 4.11 Vcare Pharmatech
- 4.11.1 Vcare Pharmatech Sotagliflozin Company Information
- 4.11.2 Vcare Pharmatech Sotagliflozin Business Overview
- 4.11.3 Vcare Pharmatech Sotagliflozin Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Vcare Pharmatech Product Portfolio
- 4.11.5 Vcare Pharmatech Recent Developments
5 Global Sotagliflozin Production by Region
- 5.1 Global Sotagliflozin Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sotagliflozin Production by Region: 2021-2032
- 5.2.1 Global Sotagliflozin Production by Region: 2021-2026
- 5.2.2 Global Sotagliflozin Production Forecast by Region (2027-2032)
- 5.3 Global Sotagliflozin Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Sotagliflozin Production Value by Region: 2021-2032
- 5.4.1 Global Sotagliflozin Production Value by Region: 2021-2026
- 5.4.2 Global Sotagliflozin Production Value Forecast by Region (2027-2032)
- 5.5 Global Sotagliflozin Market Price Analysis by Region (2021-2026)
- 5.6 Global Sotagliflozin Production and Value, YOY Growth
- 5.6.1 North America Sotagliflozin Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Sotagliflozin Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Sotagliflozin Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Sotagliflozin Production Value Estimates and Forecasts (2021-2032)
6 Global Sotagliflozin Consumption by Region
- 6.1 Global Sotagliflozin Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sotagliflozin Consumption by Region (2021-2032)
- 6.2.1 Global Sotagliflozin Consumption by Region: 2021-2026
- 6.2.2 Global Sotagliflozin Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sotagliflozin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sotagliflozin Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sotagliflozin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sotagliflozin Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sotagliflozin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sotagliflozin Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Sotagliflozin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Sotagliflozin Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Sotagliflozin Production by Type (2021-2032)
- 7.1.1 Global Sotagliflozin Production by Type (2021-2032) & (t)
- 7.1.2 Global Sotagliflozin Production Market Share by Type (2021-2032)
- 7.2 Global Sotagliflozin Production Value by Type (2021-2032)
- 7.2.1 Global Sotagliflozin Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Sotagliflozin Production Value Market Share by Type (2021-2032)
- 7.3 Global Sotagliflozin Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Sotagliflozin Production by Application (2021-2032)
- 8.1.1 Global Sotagliflozin Production by Application (2021-2032) & (t)
- 8.1.2 Global Sotagliflozin Production Market Share by Application (2021-2032)
- 8.2 Global Sotagliflozin Production Value by Application (2021-2032)
- 8.2.1 Global Sotagliflozin Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Sotagliflozin Production Value Market Share by Application (2021-2032)
- 8.3 Global Sotagliflozin Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Sotagliflozin Value Chain Analysis
- 9.1.1 Sotagliflozin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Sotagliflozin Production Mode & Process
- 9.2 Sotagliflozin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sotagliflozin Distributors
- 9.2.3 Sotagliflozin Customers
10 Global Sotagliflozin Analyzing Market Dynamics
- 10.1 Sotagliflozin Industry Trends
- 10.2 Sotagliflozin Industry Drivers
- 10.3 Sotagliflozin Industry Opportunities and Challenges
- 10.4 Sotagliflozin Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst